TNNT2 and coronary artery disorder: Elevated hs-cTnT concentrations before the procedure highlight the older age of this patient cohort (median age 82.5 years) and the high prevalence of cardiovascular morbidities, such as coronary artery disease (60%), hypertension (83%), or impaired renal function (62% with eGFR ≤ 60 ml/min/1.73 m2).